Vinergy Developing and Investing in the Next Generation of A.I. Driven Health Care
An Emerging Markets Sponsored Commentary
ORLANDO, Fla, Sept. 27, 2023 (GLOBE NEWSWIRE) — Health care is always changing, evolving, endeavoring to be better for the patient and to be more profitable for the providers. In a perfect world, these separate needs align.
Rarely do they.
Today’s featured Company, Vinergy Capital Inc. (the “Company” or “Vinergy”) (CSE:VIN, OTCQB:VNNYF, FSE:1V7), has a plan for and is aggressively investing in what could be the next generation of ultra personalized and profitable health care designed to be a win/win for all involved.
Let’s start with the recognition that the health care experience for many Americans is wholly unsatisfying. Complaints range from misdiagnosis to horrible wait times. It can literally add insult to injury.
And the reality is that many patients are willing to pay a premium for better, more efficient care. Using concierge doctors or paying cash to see a preferred specialist out of your insurance’s plan are common choices. The market appetite is clear.
Enter into the equation the power of Artificial Intelligence which can dramatically enhance margins and the health care experience. That’s Vinergy’s core mission and the AI Healthcare market isn’t just clear, it’s enormous.
One recent research report by a firm completely unrelated to Vinergy projects that the “Worldwide Artificial Intelligence in Healthcare Market Size is expected to reach USD 280.77 Billion by 2032.” (source link.)
To this end, earlier this month Vinergy announced that it has a non-binding Letter of Intent (LOI) to acquire a 4% interest in a health care AI Platform (AIP) that has developed a cutting edge FDA and HIPAA compliant data and analysis platform specifically for drug development and laboratory applications. Better yet, the AIP is already generating revenue from its intellectual property and products with blue chip customers, which for us inspires some real confidence.
If the Company is already earning, then the tech is proven in the marketplace. If it’s proven by blue chip customers, well then, that’s an order of magnitude more confidence inspiring.
Too often we see great ideas sold as earners that are still in a nascent, beta, or concept state especially in white-hot markets like A.I.
And it doesn’t hurt that we had all this explained to us by a veteran health care executive and Yale lecturer who has come on board at Vinergy and has been appointed to the investment committee of the Company and will act as its Chair.
If the LOI consummates, and it’s a reasonable expectation that it will, it will add to a compelling AI/Health Care portfolio that recently added another A.I. significant piece vis-à-vis purchasing nearly half of Healthcare Accretion Group which was founded by a diverse assemblage of professionals with backgrounds that include elite institutions like Yale/New Haven Hospital, Harvard, Cornell and more. This team has come together in this unique time to lever the quickly burgeoning potential of artificial intelligence and machine learning to healthcare services market.
Again, Vinergy and its shareholders own 49% of the Company now.
We intend to publish more going forward about the Company’s plans to use AI to change outcomes for patients and providers as more develops.
But right now we wanted to make a first introduction to a Company full of smart minds looking to put smart money into one of the deepest verticals on the planet.
About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing decades of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.
For more informative reports such as this, please sign up at: https://emergingmarketsconsulting.com/
Must Read OTC Markets/SEC policy on stock promotion and investor protection
Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.
EMC has been paid $90,000 by Vinergy Capital, Inc. EMC does not independently verify any of the content linked-to from this editorial. | Please read our full disclaimer.
Emerging Markets Consulting, LLC
390 N Orange Ave. Suite 2300
Orlando, FL 32801
- Victorious Family IgnitesNationwide Movement for Family Discipleship - December 6, 2023
- India Decorative Veneer Business to Reach US$ 376.3 million in 2033 Amid Growing Real Estate and Interior Design Industries | Future Market Insights, Inc. - December 6, 2023
- INVESTOR ALERT: Abbott Cooper PLLC Investigates Crown Castle, Inc.; Urges Crown Castle Stockholders to Contact Abbott Cooper Regarding Their Legal Rights - December 6, 2023